The existence of the both group in this study reflects TMM dynamics during glioma progression; there is also considerable evidence that telomerase activation and ALT can coexist within a single tumor or may undergo a mutual shift during cancer progression in relation to anticancer therapy or EMT [19–25, 61–64]. This evidence concerns the gene GPT and central nervous system cancer.